|
KR20200127480A
|
|
Crystalline Forms of Teneligliptin Edisylate and Process of Preparing the Same
|
|
KR20200122826A
|
|
Process for Preparing Naldemedine
|
|
WO2019093776A1
|
|
Intermediate for preparing eribulin mesylate and method for preparing same
|
|
KR20200008373A
|
|
Orally Disintegrating Tablet Comprising Nalfurafine
|
|
KR20190000316A
|
|
Eye Drop Composition for Treating Glaucoma
|
|
KR20190135312A
|
|
Process for Preparing Sugammadex Sodium
|
|
KR20180057582A
|
|
Process for Preparing Eldecalcitol and Intermediate Therefor
|
|
WO2018124847A1
|
|
Production intermediate of eribulin mesylate, and method for producing same
|
|
KR101991710B1
|
|
Intermediate for Preparing Eribulin Mesylate and Process for Preparing the Same
|
|
KR20190028109A
|
|
Sustained Release Formulation Comprising Blonanserin
|
|
KR20190016820A
|
|
Process for Preparing Latanoprostene bunod and Intermediate Therefor
|
|
KR20180128201A
|
|
Crystalline Form of Nalfurafine and Process of Preparing the Same
|
|
KR20180116959A
|
|
Process for Preparing Tacalcitol and Intermediate Therefor
|
|
KR20180079781A
|
|
Intermediate for Preparing Eribulin Mesylate and Process for Preapring the Same
|
|
KR20180057017A
|
|
Process for Preparing Crystal of Eldecalcitol
|
|
KR20180057033A
|
|
Process for Preparing Eldecalcitol and Intermediate Therefor
|
|
KR101777633B1
|
|
Process for Preparing Beraprost Intermediate
|
|
KR20170123442A
|
|
Process for Preparing Beraprost Intermediate
|
|
KR20170123132A
|
|
Process for Preparing Treprostinil
|
|
KR20170123126A
|
|
Process for Preparing Treprostinil and Intermediate Therefor
|
